Press Releases
Chronic Lymphocytic Leukemia (CLL) Therapeutics Market Analysis and Demand Forecast to 2023

United States, 20 May 2017 -- The global chronic lymphocytic leukemia therapeutics market is expected to create more opportunities in oncology due to promising pipeline and positive clinical data of drug candidates.

The existing drugs for the treatment of chronic lymphocytic leukemia is the be most effective treatment. The American Cancer Society, and other regulatory bodies are supporting the chronic lymphocytic leukemia therapeutics market by providing funding and grants. The market is being driven by different factors such as rising awareness for the cancer treatments, high demand for safe and effective medications, technologies advancements, and increasing prevalence of cancer.

Explore Report at:

Chronic lymphocytic leukemia is a type of gradually developing leukemia that affects the development of B lymphocytes (also known as B cells). On the other hand, B cells are specialized white blood cells, which produce immunoglobulins (also called antibodies) under normal conditions, and help to protect the human body against infections and diseases. In patients with chronic lymphocytic leukemia, lymphocytes undergo a malignant change and become leukemic cells.
The stability of chronic lymphocytic leukemia varies form months to years in a person and shows its impact on their lifestyle and general health. It is estimated that around 30.0% of people, diagnosed with chronic lymphocytic leukemia, do not need any treatment for their disease and can survive for many years despite their diagnosis. In some patients, the leukemic cells multiply rapidly in an uncontrolled manner making them unable to function properly. The abnormal cells get stored in the bone marrow, blood stream, lymph nodes, spleen, liver and other parts of the body for a long period of time. After an exceeded time period, a large number of lymphocytes deposit in the bone marrow and can impact the normal blood cell production. The bone marrow produces an insufficient number of red cells, whereas white blood cells and platelets are normal. This makes the patient more susceptible to anemia, recurrent infections and bruising and bleeding.

Request for Table of Content at:

The chronic lymphocytic leukemia is more prevalent in North America, making the region to be the largest revenue contributor, globally. The U.S. contributed the largest revenue to the North American market in year 2016, and it is expected to remain the largest market across the globe, during the forecast period.

Some of the key players operating in the chronic lymphocytic leukemia therapeutics market are GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Celgene Corporation, Biogen Inc., AbbVie, Inc., Teva Pharmaceuticals Limited, Gilead Sciences, Inc., Novartis AG, and Johnson & Johnson.

# # #

Submitted by Jacob, P&S Market Research on Saturday, 20 May 2017 at 5:03 AM
Category: Health Care & Medical
Related News

Bostondentaluae.Com the Best Dental Solution Provides In Abu Dhabi
Saturday, 19 Aug 2017

Bostondentaluae.Com Providing Exceptional Dental Care to Patients for Years
Saturday, 19 Aug 2017

American Center for Psychiatry and Neurology Provides Treatment for Varied Neurological Disorders
Friday, 18 Aug 2017

Signs You May Have a Termite Infestation Problem
Friday, 18 Aug 2017

Highlands Ranch, CO - Best Medical marijuana dispensaries
Friday, 18 Aug 2017

Related Events

Mayo Clinic Approaches to Pediatric Mood and Related Disorders 2017
Friday, 18 Aug 2017

Mayo Clinic Hematology, Oncology and Blood and Marrow Transplant for NPs and PAs
Friday, 18 Aug 2017

Systemic Constellations Workshop with Luke Maddocks London August 2017
Saturday, 19 Aug 2017

ISN-ESN Biennial Meeting
Sunday, 20 Aug 2017

IPF Summit
Monday, 21 Aug 2017

Latest News

Is a Cat Scratching Post Necessary?
Saturday, 19 Aug 2017

Bostondentaluae.Com the Best Dental Solution Provides In Abu Dhabi
Saturday, 19 Aug 2017

5 Issues to know Ahead of Taking into consideration a Puppy Daycare
Saturday, 19 Aug 2017

Why Do You Need a Rabbit Hutch?
Saturday, 19 Aug 2017

Should You Check Out Luxury Dog Beds?
Saturday, 19 Aug 2017

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2017
Today is Saturday, 19 August 2017

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Ultrafine mill grinding market has great potential
  • Mayo Clinic Approaches to Pediatric Mood and Related Disorders 2017
  • Recruitment & Selection Techniques: Hiring the Right People
  • Mayo Clinic Hematology, Oncology and Blood and Marrow Transplant for NPs and PAs
  • Queen City Entrepreneurs Conference

  • Latest Jobs
  • Gold Ore Milling Machine Advantages
  • London Investment Property
  • We Are Hiring A Content Manager!